Skip to main content
. 2020 Mar 19;21(6):2118. doi: 10.3390/ijms21062118
APAF1 apoptotic peptidase-activating factor 1
AR-V7 androgen receptor variant 7
CAFs cancer-associated fibroblast
CRPC castrate-resistant prostate cancer
CTCs circulating tumor cells
EGFR epidermal growth factor receptor
EMT epithelial–mesenchymal transition
EV extracellular vesicles
FASL ligand Fas
HIF-1α hypoxia-inducible factor 1α
HSP heat shock proteins
ITGB4 integrin β4
MICs metastases-initiating cells
miR micro RNA
MMP matrix metalloproteinase
MVBs multivesicular bodies
PCa prostate cancer
PDCD4 programmed cell death 4
PDL-1 programmed death ligand 1
PSA prostate specific antigen
RANKL receptor activator for nuclear factor κB ligand
RSU1 Ras suppressor protein 1
siRNA small interfering RNA
STAG2 cohesin subunit SA-2
TDSFs tumor-derived secreted factors
TGFβ transforming growth factor β
VCL vinculin